Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 6/2019

12.03.2019 | Original Article

18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging

verfasst von: Sophie Turpin, Patrick Martineau, Marc-André Levasseur, Inge Meijer, Jean-Claude Décarie, Julie Barsalou, Christian Renaud, Hélène Decaluwe, Elie Haddad, Raymond Lambert

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

FDG PET/CT is emerging as a new tool for the evaluation of acute encephalitis (AE). However, to date, there are no exclusively pediatric studies on the use of FDG PET for suspected AE. The objective of this study was to compare qualitative and quantitative brain PET to conventional brain imaging in a cohort of children, and to identify patterns of metabolic abnormalities characteristic of AE.

Methods

This retrospective study included 34 children imaged with PET/CT, CT and magnetic resonance imaging (MRI). The positivity rate of all three imaging modalities was measured. Besides visual assessment, quantification of relative regional brain metabolism (RRBM) was performed and compared to a database of normal pediatric brains.

Results

Fourteen subjects had a clinical diagnosis of autoimmune encephalitis (AIE) or encephalitis of unknown origin (EX), six of anti-N-methyl-D-aspartate receptor (anti-NMDAr) encephalitis, three of Hashimoto’s encephalopathy, three of neurolupus and eight had other subtypes of encephalitis.
Quantitative PET was abnormal in 100% of cases, visually assessed PET in 94.1% of subjects, MRI in 41.2% and CT in 6.9%. RRBM quantification demonstrated multiple hyper and hypo metabolic cortical regions in 82.3% of subjects, exclusively hypermetabolic abnormalities in 3%, and exclusively hypometabolic abnormalities in 14.7%. The basal ganglia were hypermetabolic in 26.5% of cases on visual assessment and in 58.8% of subjects using quantification.

Conclusion

In our pediatric population FDG PET was more sensitive than conventional imaging for the detection of AE, and basal ganglia hypermetabolism was frequently encountered.
Literatur
2.
3.
Zurück zum Zitat Dale RC, Gorma MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics and emerging challenges. Curr Opin Neurol. 2017;30:334–44.CrossRefPubMed Dale RC, Gorma MP, Lim M. Autoimmune encephalitis in children: clinical phenomenology, therapeutics and emerging challenges. Curr Opin Neurol. 2017;30:334–44.CrossRefPubMed
4.
Zurück zum Zitat Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Celluci T, et al. A clinical approach for the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRefPubMedPubMedCentral Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Celluci T, et al. A clinical approach for the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar B, et al. Case definitions, diagnosis algorithms and priorities: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.CrossRefPubMedPubMedCentral Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar B, et al. Case definitions, diagnosis algorithms and priorities: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies with encephalitis. Clin Infect Dis. 2006;43:1565–57.CrossRefPubMed Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies with encephalitis. Clin Infect Dis. 2006;43:1565–57.CrossRefPubMed
8.
Zurück zum Zitat Sominer FE. Autoimmune encephalitis: history and current knowledge. Copenhagen: Statens Serum Institut; 2016. Version 5.8. Sominer FE. Autoimmune encephalitis: history and current knowledge. Copenhagen: Statens Serum Institut; 2016. Version 5.8.
9.
Zurück zum Zitat Morbelli S, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, et al. On behalf of the EANM and SNMMI. The need for standardization and of large clinical studies in an emerging indication of 18F- FDG: the auto-immune encephalitis. Eur J Nucl Med Mol Imaging. 2017;44:353–7. Morbelli S, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, et al. On behalf of the EANM and SNMMI. The need for standardization and of large clinical studies in an emerging indication of 18F- FDG: the auto-immune encephalitis. Eur J Nucl Med Mol Imaging. 2017;44:353–7.
10.
Zurück zum Zitat Turpin S, Martineau PJ, Levasseur MA, Lambert R. Modeling the effects of age and gender on normal pediatric brain metabolism using 18F-FDG PET/CT. J Nucl Med. 2018;59:1118–24.CrossRefPubMed Turpin S, Martineau PJ, Levasseur MA, Lambert R. Modeling the effects of age and gender on normal pediatric brain metabolism using 18F-FDG PET/CT. J Nucl Med. 2018;59:1118–24.CrossRefPubMed
11.
Zurück zum Zitat Melzer N, Meuth SG, Wiendl H. Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol. 2013;260:1215–33.CrossRefPubMed Melzer N, Meuth SG, Wiendl H. Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system. J Neurol. 2013;260:1215–33.CrossRefPubMed
12.
Zurück zum Zitat Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune disease of the central nervous system. Physiol Rev. 2017;97:839–87.CrossRefPubMedPubMedCentral Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune disease of the central nervous system. Physiol Rev. 2017;97:839–87.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Pignolet BSL, Gebauer CMT, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies. A beneficial antitumor immune response going awry. OncoImmunology. 2013;2:e27384. (1–10). Pignolet BSL, Gebauer CMT, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies. A beneficial antitumor immune response going awry. OncoImmunology. 2013;2:e27384. (1–10).
14.
Zurück zum Zitat Gable MS, Sherriff H, Dalmau J, Tilleu DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54:899–904.CrossRefPubMedPubMedCentral Gable MS, Sherriff H, Dalmau J, Tilleu DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54:899–904.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Erlich DJ, Walker EH. Functional neuroimaging and chorea: a systematic review. J Clin Mov Disord. 2017;4:8–27.CrossRef Erlich DJ, Walker EH. Functional neuroimaging and chorea: a systematic review. J Clin Mov Disord. 2017;4:8–27.CrossRef
16.
Zurück zum Zitat Delle AcqueGiogio SM, Caprio MG, Galante F, Russo G, Romano A, Vergara E, et al. Clinical value of perfusion abnormalities of brain on Technitium-9m HMPAO single photon emission computed tomography in children with Sydenham chorea. J Child Neurol. 2017;32:316–21. Delle AcqueGiogio SM, Caprio MG, Galante F, Russo G, Romano A, Vergara E, et al. Clinical value of perfusion abnormalities of brain on Technitium-9m HMPAO single photon emission computed tomography in children with Sydenham chorea. J Child Neurol. 2017;32:316–21.
17.
Zurück zum Zitat Ho L. Hypermetabolism in bilateral basal ganglia in Sydenham chorea on 18F-FDG PET/CT. Clin Nucl Med. 2009;34:114–6.CrossRefPubMed Ho L. Hypermetabolism in bilateral basal ganglia in Sydenham chorea on 18F-FDG PET/CT. Clin Nucl Med. 2009;34:114–6.CrossRefPubMed
18.
Zurück zum Zitat Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013;260:2744–53.CrossRefPubMed Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013;260:2744–53.CrossRefPubMed
19.
Zurück zum Zitat Solnes LB, Jones KM, Rowe SP, Pattanayak P, Nalluri A, Venkatesan A, et al. Diagnostic value of 18F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med. 2017;58:1307–13.CrossRefPubMed Solnes LB, Jones KM, Rowe SP, Pattanayak P, Nalluri A, Venkatesan A, et al. Diagnostic value of 18F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med. 2017;58:1307–13.CrossRefPubMed
20.
Zurück zum Zitat Tripathi M, Tripathi M, Roy SG, Parida GK, Ihtisham K, Dash D, et al. Metabolic topography of autoimmune non-paraneoplastic encephalitis. Neuroradiology. 2018;60:189–98.CrossRefPubMed Tripathi M, Tripathi M, Roy SG, Parida GK, Ihtisham K, Dash D, et al. Metabolic topography of autoimmune non-paraneoplastic encephalitis. Neuroradiology. 2018;60:189–98.CrossRefPubMed
21.
Zurück zum Zitat Lagarde S, Lepine A, Caietta E, Pelletier F, Boucrot J, Chabrol B, et al. Cerebral 18 FluoroDeoxyglucose positron emission tomography in paediatric anti N-Metyl-D-aspartate receptor encephalitis: a case series. Brain and Development. 2016;38:461–70.CrossRefPubMed Lagarde S, Lepine A, Caietta E, Pelletier F, Boucrot J, Chabrol B, et al. Cerebral 18 FluoroDeoxyglucose positron emission tomography in paediatric anti N-Metyl-D-aspartate receptor encephalitis: a case series. Brain and Development. 2016;38:461–70.CrossRefPubMed
22.
Zurück zum Zitat Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Decreased occipital lobe metabolism by FDG PET/CT: an anti-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm. 2018;5:e413–9.CrossRefPubMed Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Decreased occipital lobe metabolism by FDG PET/CT: an anti-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm. 2018;5:e413–9.CrossRefPubMed
23.
Zurück zum Zitat Leypoldt F, Buchert R, Kleiter I, Mariehagen J, Gelderblom M, Magnus T, et al. Fluorodeoxyglucose positron emission tomography in anti-Nmethyl-D-aspartate receptor encephalitis; distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83:681–6.CrossRefPubMedPubMedCentral Leypoldt F, Buchert R, Kleiter I, Mariehagen J, Gelderblom M, Magnus T, et al. Fluorodeoxyglucose positron emission tomography in anti-Nmethyl-D-aspartate receptor encephalitis; distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012;83:681–6.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yuan J, Guan H, Zhou X, Niu N, Li F, Cui L, et al. Changing brain metabolism patterns in subjects with ANMDARE: serial 18F-FDG PET/CT findings. Clin Nucl Med. 2016;41:1–5.CrossRef Yuan J, Guan H, Zhou X, Niu N, Li F, Cui L, et al. Changing brain metabolism patterns in subjects with ANMDARE: serial 18F-FDG PET/CT findings. Clin Nucl Med. 2016;41:1–5.CrossRef
25.
Zurück zum Zitat Pillai SC, Gill D, Webster R, Howman-Giles R, Dale RC. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol. 2010;43:218–20.CrossRef Pillai SC, Gill D, Webster R, Howman-Giles R, Dale RC. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol. 2010;43:218–20.CrossRef
27.
Zurück zum Zitat Strauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581–8.CrossRef Strauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581–8.CrossRef
28.
Zurück zum Zitat Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of 18F-Fluorodeoxyglucose PET. Ann Rheum Dis. 2000;59:377–85.CrossRefPubMedPubMedCentral Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of 18F-Fluorodeoxyglucose PET. Ann Rheum Dis. 2000;59:377–85.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Lee SW, Park MC, Lee SK, Park YB. The efficacy of brain 18F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus subjects with normal brain magnetic resonance imaging findings. Lupus. 2012;21:1531–7.CrossRefPubMed Lee SW, Park MC, Lee SK, Park YB. The efficacy of brain 18F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus subjects with normal brain magnetic resonance imaging findings. Lupus. 2012;21:1531–7.CrossRefPubMed
30.
Zurück zum Zitat Nowak M, Carrasquillo JA, Yarboro CH, Bacharach SL, Whatley M, et al. A pilot study of the use of FDG PET to assess the distribution of activated lymphocytes in subjects with SLE. Arthritis Rheum. 2004;50:1233–8.CrossRefPubMed Nowak M, Carrasquillo JA, Yarboro CH, Bacharach SL, Whatley M, et al. A pilot study of the use of FDG PET to assess the distribution of activated lymphocytes in subjects with SLE. Arthritis Rheum. 2004;50:1233–8.CrossRefPubMed
31.
Zurück zum Zitat Pari E, Rinaldi F, Premi E, Codella M, Renata R, Paghera B, et al. A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status-epileptic treated with plasmapheresis. J Neurol. 2014;261:663–7.CrossRefPubMed Pari E, Rinaldi F, Premi E, Codella M, Renata R, Paghera B, et al. A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status-epileptic treated with plasmapheresis. J Neurol. 2014;261:663–7.CrossRefPubMed
32.
Zurück zum Zitat Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, et al. Effects of haloperidol challenge in regional glucose utilization in normal human subjects. Am J Psychiatry. 1994;151:681–8.CrossRefPubMed Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, et al. Effects of haloperidol challenge in regional glucose utilization in normal human subjects. Am J Psychiatry. 1994;151:681–8.CrossRefPubMed
33.
Zurück zum Zitat Wang GJ, Volkow ND, Fowler JS, Hitzemann RJ, Pappas NR, Netuzil N. Evaluation of gender differences in regional brain metabolic responses to lorazepam. Psychiatry Res (Neuro). 1998;82:37–47.CrossRef Wang GJ, Volkow ND, Fowler JS, Hitzemann RJ, Pappas NR, Netuzil N. Evaluation of gender differences in regional brain metabolic responses to lorazepam. Psychiatry Res (Neuro). 1998;82:37–47.CrossRef
34.
Zurück zum Zitat Laaksonen L, Kallioinene M, Långsjö J, Laitio T, Scheinin A, Scheinin J, et al. Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on the regional cerebral glucose metabolism in humans: a positron emission tomography study. Br J Anaesth. 2018;121:281–90.CrossRefPubMed Laaksonen L, Kallioinene M, Långsjö J, Laitio T, Scheinin A, Scheinin J, et al. Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on the regional cerebral glucose metabolism in humans: a positron emission tomography study. Br J Anaesth. 2018;121:281–90.CrossRefPubMed
35.
Zurück zum Zitat Zhu Y, Feng J, Wu S, Hou H, Ji J, Zhang K, et al. Glucose metabolic profile by visual assessment combined with statistical parametric mapping analysis in pediatric patients with epilepsy. J Nucl Med. 2017;58:1293–9.CrossRefPubMed Zhu Y, Feng J, Wu S, Hou H, Ji J, Zhang K, et al. Glucose metabolic profile by visual assessment combined with statistical parametric mapping analysis in pediatric patients with epilepsy. J Nucl Med. 2017;58:1293–9.CrossRefPubMed
36.
Zurück zum Zitat De Blasi B, Barnes A, Galazzo IB, Hua CH, Shulkin B, Koepp M, et al. Age-specific 18F-FDG image processing pipelines and analysis are essential for individual mapping of seizure foci in paediatric patient with intractable epilepsy. J Nucl Med. 2018;59:1590–6. De Blasi B, Barnes A, Galazzo IB, Hua CH, Shulkin B, Koepp M, et al. Age-specific 18F-FDG image processing pipelines and analysis are essential for individual mapping of seizure foci in paediatric patient with intractable epilepsy. J Nucl Med. 2018;59:1590–6.
Metadaten
Titel
18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging
verfasst von
Sophie Turpin
Patrick Martineau
Marc-André Levasseur
Inge Meijer
Jean-Claude Décarie
Julie Barsalou
Christian Renaud
Hélène Decaluwe
Elie Haddad
Raymond Lambert
Publikationsdatum
12.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04302-x

Weitere Artikel der Ausgabe 6/2019

European Journal of Nuclear Medicine and Molecular Imaging 6/2019 Zur Ausgabe